Buffalo Clinical and Translational Research Center

布法罗临床和转化研究中心

• 批准号: 10729958
• 负责人: Timothy F Murphy
• 金额: $ 23.62万
• 依托单位: STATE UNIVERSITY OF NEW YORK AT BUFFALO
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-08-12 至 2024-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10729958
• 关键词: Acceleration; Age; Center for Translational Science Activities; Cities; Clinic; Clinical; Clinical Research; Clinical Sciences; Communities; Data; Development; Diverse Workforce; Education; Environment; Equity; Failure; Faith-based organization; Foundations; Funding; Future; Gender; Growth; Health; Health Sciences; Healthcare; Healthcare Systems; Heart; Individual; Influentials; Information Literacy; Institution; Intervention; Interview; Laboratories; Longevity; Measurement; Medical; Medical Education; Modeling; New York; Outcome; Pamphlets; Pediatric Hospitals; Population; Predictive Analytics; Process; Public Health; Public Health Informatics; Recommendation; Recording of previous events; Reduce health disparities; Research; Research Institute; Schools; Science; Services; Site; Special Population; Speed; Statistical Models; Strategic Planning; Structure; Survey Methodology; System; Target Populations; Testing; Training; Translational Research; Translations; Uncertainty; Underrepresented Minority; Universities; Vaccines; Vision; biomedical informatics; community engagement; data integration; digital media; distrust; experience; health care service; health disparity; health literacy; health organization; improved; informatics tool; innovation; marginalized population; medical schools; multiple data sources; novel; novel strategies; response; statistical learning; tool; translational pipeline; vaccine hesitancy; vaccine refusal

The Buffalo Translational Consortium (BTC), which includes the University at Buffalo (UB) health sciences schools, the major healthcare institutions in our region, four key research institutes and five influential community partners, have embarked on a comprehensive strategic plan to build a strong foundation for clinical and translational research in response to our community needs. Buffalo is the second most populous city in New York State and has a rich cultural history. The proportion of underrepresented minorities in Buffalo in 2018 (50%) parallels that projected for the US in 2050, making Buffalo a microcosm of what the US will look like in 30 years. A similar proportion of our population experiences health disparities. The vision for our CTSA hub is to perform innovative research across the translational spectrum to improve the health of our community and the nation. We will develop, test and share novel approaches to engage difficult-to-engage populations and reduce health disparities in our community, which represents a “population of the future”. Guided by our vision, the CTSA has catalyzed a transformation of our environment since our CTSA was first funded in August 2015 with remarkable growth in clinical and translational research. Further, in just the past year, the UB medical school has moved into a spectacular new building and our clinical partner, Kaleida Health, the largest healthcare system in the region, opened the new Oishei Children’s Hospital, both on the Buffalo Niagara Medical Campus and connected to the Clinical and Translational Research Center devoted entirely to clinical and translational research that opened in 2012. This rapid and continuing trajectory of growth in healthcare and research in the region has resulted in a new 21st century Academic Health Center with healthcare, medical education and clinical and translational research on one campus in the heart of Buffalo, creating a foundation to enhance the impact of our CTSA even further. While launching our CTSA, we have prioritized participation in the national consortium through hosting and testing Innovation Labs as a team science tool, working with multiple hubs on initiatives to solve translational research barriers and sharing tools that we have developed with the CTSA consortium, including novel health informatics tools. Our CTSA has five ambitious but achievable aims, including: 1) Accelerate innovative translational research with teams that engage communities, regional stakeholders and the national consortium; 2) Train an excellent, diverse workforce to advance translation of discoveries; 3) Enhance inclusion of special populations across the lifespan and difficult-to-engage populations; 4) Streamline clinical research processes focusing on quality and efficiency with emphasis on multisite studies; 5) Develop, test and share biomedical informatics tools to integrate data from multiple sources to speed translation. Guided by our vision to perform research to improve the health of our community and the nation, we will continue our momentum to expand translational research, train our diverse workforce, streamline processes, engage our community, and actively contribute to the national consortium.

布法罗转化联盟（BTC），其中包括布法罗大学（UB）健康科学大学 学校，我们地区的主要医疗机构，四家主要的研究机构和五个影响社区 合作伙伴已经制定了一项全面的战略计划，为临床和 响应我们社区需求的翻译研究。布法罗是新的第二大城市 约克州，有着丰富的文化历史。 2018年布法罗的代表性不足少数族裔的比例（50％） 在2050年向美国预计的相似之处，使布法罗成为30年来美国看起来的缩影。 我们的人口中有类似的比例经历健康分布。我们CTSA枢纽的愿景是执行 在翻译范围内的创新研究，以改善我们社区和国家的健康。 我们将开发，测试和共享新颖的方法，以吸引难以参与的人群并减少健康 我们社区中的差异代表了“未来的人口”。在我们的愿景的指导下，CTSA拥有 自CTSA于2015年8月首次资助以来，催化了我们环境的转变 临床和翻译研究的增长。此外，在过去的一年中，UB医学院已经搬进了 一座壮观的新建筑，我们的临床合作伙伴Kaleida Health是该地区最大的医疗保健系统， 开设了新的Oishei儿童医院，无论 临床和转化研究中心完全致力于开放的临床和翻译研究 2012年。该地区医疗保健和研究增长的这种快速而持续的轨迹导致 新的21世纪学术健康中心，医疗，医学教育以及临床和翻译 在布法罗中心的一个校园进行研究，为增强CTSA的影响创造了基础 更远。在启动我们的CTSA时，我们通过托管优先考虑参加国家财团 并测试创新实验室作为团队科学工具，与多个枢纽合作，以解决翻译的计划 我们与CTSA财团开发的研究障碍和共享工具，包括新颖的健康 信息工具。我们的CTSA具有五个雄心勃勃但可实现的目标，包括：1）加速创新 与社区，区域利益相关者和国家财团的团队翻译研究； 2）培训优秀的潜水员劳动力，以提高发现的翻译； 3）增强特殊包含 整个生命周期和难以参与的人群； 4）简化临床研究过程 专注于质量和效率，重点是多站点研究； 5）开发，测试和共享生物医学 信息工具可以将来自多个来源的数据集成到速度翻译。以我们的愿景为指导 为了改善社区和国家的健康的研究，我们将继续我们的势头 翻译研究，培训我们多样化的劳动力，简化流程，吸引我们的社区，并积极地 为国家财团做出贡献。